Publicacións en colaboración con investigadores/as de Instituto Nacional de Cardiología (9)

2024

  1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  2. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study

    Circulation: Heart Failure, Vol. 17, Núm. 1, pp. E011105

2023

  1. Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial

    JACC: Heart Failure, Vol. 11, Núm. 12, pp. 1729-1738

2022

  1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

    New England Journal of Medicine, Vol. 387, Núm. 11, pp. 978-988

2021

  1. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

  2. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4685-4692

2020

  1. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials

    European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171

  2. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation

    American Heart Journal, Vol. 225, pp. 69-77

2011

  1. Estrategias de colaboración para la red de revistas Cardiovasculares iberoamericanas

    Archivos de Cardiologia de Mexico, Vol. 81, Núm. 3, pp. 273-276